OVERLAND PARK, Kan.–(BUSINESS WIRE)–Dr. Vince Clinical Research (DVCR), today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas. The custom-built, green-inspired research complex was intentionally designed and engineered — with significant investments in infrastructure, research-changing technologies, employee wellness and excellence and environmental sustainability — to be the premier destination in the country for Phase I clinical studies.
Dr. Vince Clinical Research, specializing in early phase clinical trials, opens its world-class research center in Overland Park, Kansas, with features unlike any other in the industry.Tweet this
Dedicated to Phase I Clinical Trials
“Our vision was to create the top clinical pharmacology unit in the U.S. that enables delivering faster and cleaner data to our biopharmaceutical clients,” said Brad Vince, D.O., a 20-year industry veteran and founder, CEO and medical director. “To accomplish our goals and transform standard industry practices, we built one of the most innovative and technologically advanced Phase I sites ever.”
The company leveraged a robust team of engineers and consultants to plan and construct the new facility and help ensure seamless deployment of the latest technologies for both the physical infrastructure of the 90-bed center and company operations and processes. These key technologies enable the company to deliver higher quality data more efficiently than current industry standards, including:
- eSource/EDC platform with equipment integration for automated data upload
- Automated building and inventory management systems
- Cloud-based environmental monitoring of pharmacy areas
- Clean lighting technology for killing COVID and other pathogens
Investing in People
The company designed the facility to be one of the world’s most luxurious research centers in order to deliver unrivaled study volunteer recruitment and retention. “However, the facility alone is not enough to create the optimal environment for conducting Phase I trials,” Dr. Vince continued. “The team overseeing a trial is crucial to the execution and success of any clinical study, so we carefully and thoughtfully assembled one of the most experienced early phase leadership teams in the industry so we can provide unparalleled service to our sponsors and positively change the future of clinical research.”
Website: https://sponsors.drvince.com
LinkedIn: https://www.linkedin.com/company/dr-vince-clinical-research/
About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.
For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube.
Contact
Zach Bader
Vice President, Business Development
913-333-3000
zbader@drvince.com